Skip to Content

Diaceutics PLC DXRX

Morningstar Rating
GBX 104.50 +0.50 (0.48%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

DXRX is trading at a 14% discount.
Price
GBP 103.89
Fair Value
GBP 734.29
Uncertainty
Very High
1-Star Price
GBP 576.19
5-Star Price
GBP 42.77
Economic Moat
Bgxz
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if DXRX is a good fit for your portfolio.

Trading Information

Previous Close Price
GBX 104.00
Day Range
GBX 104.00104.50
52-Week Range
GBX 79.00110.00
Bid/Ask
GBX 102.00 / GBX 106.00
Market Cap
GBX 8.85 Bil
Volume/Avg
54,988 / 50,914

Key Statistics

Price/Earnings (Normalized)
228.02
Price/Sales
4.11
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
0.04%

Company Profile

Diaceutics PLC is a data analytics and implementation services company that services the pharmaceutical industry. It provides the pharma and biotech companies with an end-to-end commercialization solution for the launch of precision medicine, enabled by DXRX The Diagnostic Network. DXRX is the diagnostic commercialization platform designed specifically for precision medicine, integrating multiple pipelines of real-world, real-time diagnostic testing data from a network of labs. These solutions are helping the pharma companies commercialize their precision medicines, enhance their return on investment and ultimately improve patients' lives.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Growth
Total Number of Employees
151

Comparables

Valuation

Metric
DXRX
BVXP
ZURA
Price/Earnings (Normalized)
228.0228.94
Price/Book Value
2.1420.311.58
Price/Sales
4.1117.37
Price/Cash Flow
21.7025.85
Price/Earnings
DXRX
BVXP
ZURA

Financial Strength

Metric
DXRX
BVXP
ZURA
Quick Ratio
7.746.696.11
Current Ratio
7.997.046.15
Interest Coverage
−5.64
Quick Ratio
DXRX
BVXP
ZURA

Profitability

Metric
DXRX
BVXP
ZURA
Return on Assets (Normalized)
0.94%68.76%
Return on Equity (Normalized)
1.06%77.21%
Return on Invested Capital (Normalized)
0.52%76.10%
Return on Assets
DXRX
BVXP
ZURA
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncSwmfgkgbwHbhx$220.9 Bil
DHR
Danaher CorpPyjxlfrccCzgfzrj$184.0 Bil
IQV
IQVIA Holdings IncTvmpmjvqWvxrfwj$46.0 Bil
IDXX
IDEXX Laboratories IncSjswqgwfBhzfqbw$44.8 Bil
A
Agilent Technologies IncLcggqhxmfHbvg$43.2 Bil
MTD
Mettler-Toledo International IncGwlvxhydTgsht$28.6 Bil
ICLR
Icon PLCPstrvhnlJqdkmyk$27.2 Bil
ILMN
Illumina IncNtxlsxmKhfxw$22.0 Bil
WAT
Waters CorpXwrdvsdbTpr$20.4 Bil
LH
Laboratory Corp of America HoldingsBtgrgwkwVcptz$18.2 Bil

Sponsor Center